Report Detail
Global All Vaccine Market Insights, Forecast to 2025
- RnM2848694 |
- 31 January, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The average price of China All Vaccine is in the increasing trend, from 2.93 USD/Dose in 2012 to 4.27 USD/Dose in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of China All Vaccine includes Polio, Pertussis, Diphtheria, Tetanus, BCG, Rabies, Hepatitis B, Pneumococcal, Hepatitis A, Varicella, Influenza and others and the proportion of Pertussis, Diphtheria and Tetanus in 2016 is about 20.15%, and the proportion is in fluctuation trend from 2012 to 2016.
The global All Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the All Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of All Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of All Vaccine in these regions.
This research report categorizes the global All Vaccine market by top players/brands, region, type and end user. This report also studies the global All Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR
Novartis
GSK
Market size by Product
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others
Market size by End User
For Adult
For Child
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global All Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of All Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global All Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of All Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of All Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of All Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 All Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global All Vaccine Market Size Growth Rate by Product
- 1.4.2 Varicella
- 1.4.3 Influenza
- 1.4.4 Polio
- 1.4.5 Hepatitis A
- 1.4.6 Rabies
- 1.4.7 BCG
- 1.4.8 Hepatitis B
- 1.4.9 Pertussis, Diphtheria, tetanus
- 1.4.10 Pneumococcal
- 1.4.11 Others
- 1.5 Market by End User
- 1.5.1 Global All Vaccine Market Size Growth Rate by End User
- 1.5.2 For Adult
- 1.5.3 For Child
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global All Vaccine Market Size
- 2.1.1 Global All Vaccine Revenue 2014-2025
- 2.1.2 Global All Vaccine Sales 2014-2025
- 2.2 All Vaccine Growth Rate by Regions
- 2.2.1 Global All Vaccine Sales by Regions
- 2.2.2 Global All Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 All Vaccine Sales by Manufacturers
- 3.1.1 All Vaccine Sales by Manufacturers
- 3.1.2 All Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global All Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 All Vaccine Revenue by Manufacturers
- 3.2.1 All Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 All Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 All Vaccine Price by Manufacturers
- 3.4 All Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 All Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers All Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into All Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global All Vaccine Sales by Product
- 4.2 Global All Vaccine Revenue by Product
- 4.3 All Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global All Vaccine Breakdown Data by End User
6 North America
- 6.1 North America All Vaccine by Countries
- 6.1.1 North America All Vaccine Sales by Countries
- 6.1.2 North America All Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America All Vaccine by Product
- 6.3 North America All Vaccine by End User
7 Europe
- 7.1 Europe All Vaccine by Countries
- 7.1.1 Europe All Vaccine Sales by Countries
- 7.1.2 Europe All Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe All Vaccine by Product
- 7.3 Europe All Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific All Vaccine by Countries
- 8.1.1 Asia Pacific All Vaccine Sales by Countries
- 8.1.2 Asia Pacific All Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific All Vaccine by Product
- 8.3 Asia Pacific All Vaccine by End User
9 Central & South America
- 9.1 Central & South America All Vaccine by Countries
- 9.1.1 Central & South America All Vaccine Sales by Countries
- 9.1.2 Central & South America All Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America All Vaccine by Product
- 9.3 Central & South America All Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa All Vaccine by Countries
- 10.1.1 Middle East and Africa All Vaccine Sales by Countries
- 10.1.2 Middle East and Africa All Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa All Vaccine by Product
- 10.3 Middle East and Africa All Vaccine by End User
11 Company Profiles
- 11.1 CNBG
- 11.1.1 CNBG Company Details
- 11.1.2 Company Business Overview
- 11.1.3 CNBG All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 CNBG All Vaccine Products Offered
- 11.1.5 CNBG Recent Development
- 11.2 ChengDa Bio
- 11.2.1 ChengDa Bio Company Details
- 11.2.2 Company Business Overview
- 11.2.3 ChengDa Bio All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 ChengDa Bio All Vaccine Products Offered
- 11.2.5 ChengDa Bio Recent Development
- 11.3 Changsheng Life
- 11.3.1 Changsheng Life Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Changsheng Life All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Changsheng Life All Vaccine Products Offered
- 11.3.5 Changsheng Life Recent Development
- 11.4 Zhifei
- 11.4.1 Zhifei Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Zhifei All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Zhifei All Vaccine Products Offered
- 11.4.5 Zhifei Recent Development
- 11.5 SINOVAC BIOTECH
- 11.5.1 SINOVAC BIOTECH Company Details
- 11.5.2 Company Business Overview
- 11.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 SINOVAC BIOTECH All Vaccine Products Offered
- 11.5.5 SINOVAC BIOTECH Recent Development
- 11.6 NuoCheng Bio
- 11.6.1 NuoCheng Bio Company Details
- 11.6.2 Company Business Overview
- 11.6.3 NuoCheng Bio All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 NuoCheng Bio All Vaccine Products Offered
- 11.6.5 NuoCheng Bio Recent Development
- 11.7 Hualan Bio
- 11.7.1 Hualan Bio Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Hualan Bio All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Hualan Bio All Vaccine Products Offered
- 11.7.5 Hualan Bio Recent Development
- 11.8 Kangtai
- 11.8.1 Kangtai Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Kangtai All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Kangtai All Vaccine Products Offered
- 11.8.5 Kangtai Recent Development
- 11.9 SANOFI PASTEUR
- 11.9.1 SANOFI PASTEUR Company Details
- 11.9.2 Company Business Overview
- 11.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 SANOFI PASTEUR All Vaccine Products Offered
- 11.9.5 SANOFI PASTEUR Recent Development
- 11.10 Novartis
- 11.10.1 Novartis Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Novartis All Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Novartis All Vaccine Products Offered
- 11.10.5 Novartis Recent Development
- 11.11 GSK
12 Future Forecast
- 12.1 All Vaccine Market Forecast by Regions
- 12.1.1 Global All Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global All Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 All Vaccine Market Forecast by Product
- 12.2.1 Global All Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global All Vaccine Revenue Forecast by Product 2019-2025
- 12.3 All Vaccine Market Forecast by End User
- 12.4 North America All Vaccine Forecast
- 12.5 Europe All Vaccine Forecast
- 12.6 Asia Pacific All Vaccine Forecast
- 12.7 Central & South America All Vaccine Forecast
- 12.8 Middle East and Africa All Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 All Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on All Vaccine . Industry analysis & Market Report on All Vaccine is a syndicated market report, published as Global All Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of All Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
